ClinicalTrials.Veeva

Menu

Effects of tDCS and TUS on the Perception of Pain and Functional Limitations Due to Non-Specific Chronic Low Back Pain

Mass General Brigham logo

Mass General Brigham

Status

Active, not recruiting

Conditions

Chronic Low Back Pain
Chronic Pain

Treatments

Device: transcranial Direct Current Stimulation (tDCS)
Device: Transcranial Ultrasound (TUS)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT02954432
2016P001956

Details and patient eligibility

About

The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain and functional limitations in subjects with NSCLBP. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.

Enrollment

40 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Able to provide informed consent to participate in the study
  2. Subjects between 18 to 85 years old
  3. Subjects having non-specific chronic low back pain with existing pain for at least 3 months and having pain on at least half the days in the past 6 months with an average of at least 3 on a 0-10 visual analog scale (VAS) scale
  4. Pain resistant (partial or no response) to common analgesics and medications for chronic pain used as initial pain management such as Tylenol, Aspirin, Ibuprofen, Soma, Parafon Forte DCS, Zanaflex, and Codeine.
  5. Must have the ability to feel sensation by Von-Frey fiber on the forearm

Exclusion criteria

  1. Subject is pregnant
  2. Contraindications to tDCS in conjunction with TUS, i.e. metallic implant in the brain or implanted brain medical devices
  3. History of alcohol or drug abuse within the past 6 months as self reported
  4. Use of carbamazepine within the past 6 months as self reported
  5. Suffering from severe depression (with a score of >30 in the Beck Depression Inventory)
  6. History of neurological disorders as self reported
  7. History of unexplained fainting spells as self reported
  8. History of severe head injury resulting in more than a momentary loss of consciousness as self reported
  9. History of neurosurgery as self reported
  10. Unstable pain
  11. Large placebo responder
  12. Low adherence during the run-in period
  13. Low baseline pain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

Active tDCS + Active TUS
Experimental group
Description:
Subjects in the experimental group will undergo 20 minutes of active transcranial direct current stimulation (tDCS) and active transcranial ultrasound (TUS).
Treatment:
Device: Transcranial Ultrasound (TUS)
Device: transcranial Direct Current Stimulation (tDCS)
Sham tDCS + Sham TUS
Sham Comparator group
Description:
Subjects in the sham group will undergo 20 minutes of sham transcranial direct current stimulation (tDCS) and sham transcranial ultrasound (TUS).
Treatment:
Device: Transcranial Ultrasound (TUS)
Device: transcranial Direct Current Stimulation (tDCS)

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems